LAM
ABMD

Lebenthal Asset Management’s Abiomed Inc ABMD Stock Holding History

Lebenthal Asset Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-90
Closed -$12K – 737
2016
Q3 		$12K Buy
+90
New +$10.8K ﹤0.01% 719

Other funds holding ABMD

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lebenthal Asset Management's ABMD Position: Q4 2016 in Review

Lebenthal Asset Management sold out of Abiomed Inc (ABMD) in Q4 2016, closing a stake of 90 shares — an estimated $12K sold.

Lebenthal Asset Management first reported a position in ABMD in Q3 2016 and held it in 1 quarter. The position peaked at $12K in Q3 2016. 297 funds tracked by Wall St. Rank hold ABMD as of Q4 2016.

  • Lebenthal Asset Management reported no remaining Abiomed Inc position as of Q4 2016 after selling out during the quarter.
  • Lebenthal Asset Management sold 90 Abiomed Inc shares in Q4 2016, an estimated $12K.
  • Lebenthal Asset Management first reported a position in Abiomed Inc in Q3 2016 and held it in 1 quarter.
  • Lebenthal Asset Management's Abiomed Inc position peaked at $12K in Q3 2016.
  • 297 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2016.

Based on Lebenthal Asset Management's 13F filing for Q4 2016, filed 15 Feb 2017.